Omron teams up with AHA to promote heart health
BANNOCKBURN, Ill. Blood pressure monitor manufacturer Omron Healthcare is working with the American Heart Association to promote heart health, Omron announced.
Under the partnership, Omron is supporting the AHA’s campaign to educate healthcare providers on treatments for high blood pressure, also known as hypertension, with the goal of reaching 50,000 providers by 2013.
“Omron Healthcare is proud to support the American Heart Association and its educational initiatives,” Omron COO Robert Kondraske said. “Hypertension affects 1-out-of-3 Americans and is known to be a silent killer.”
With November designated as American Diabetes Month, Omron also is promoting its blood pressure monitors for use by diabetics. Two-out-of-3 diabetes patients have hypertension, compared with 1-in-3 people in the general population, according to a 2004 study published in the journal Hypertension.
Iatrical to roll out Sippy Sure
NEW YORK Iatrical Innovations soon will launch a product designed to make giving medicine to toddlers easier.
Iatrical announced Monday the upcoming launch of Sippy Sure, a medication-dispensing sippy cup, originally invented by a doctor and father of two small children.
The cup keeps the medicine and drink separate, but mixes them as the child drinks, thus concealing the medicine.
Sippy Sure cups retail for $8.99.
FDA issues warning over use of dietary supplements containing sildenafil
SILVER SPRING, Md. — The Food and Drug Administration on Friday reported that Vigor-25, a product inappropriately marketed as a natural dietary supplement to enhance male sexual performance, should not be purchased or used because it contains sildenafil, the active ingredient in the prescription drug Viagra.
“This product is dangerous to consumers because it claims to contain only natural ingredients when it actually contains a prescription drug ingredient,” stated Deborah Autor, director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research. “Tainted products place consumers at risk of injury and death, especially those consumers with underlying health conditions.”
Vigor-25, distributed by Piston, is sold on Internet sites and possibly in some retail outlets, the FDA reported.
Sildenafil may interact with prescription drugs known as nitrates, including nitroglycerin, and can dangerously lower blood pressure. The FDA is investigating the reported death of a 26-year-old man, possibly associated with the use of Vigor-25.
The FDA has found many products marketed as dietary supplements for sexual enhancement during the past several years that can be harmful because they contain active ingredients in FDA-approved drugs or variations of these ingredients. Sexual-enhancement products promising rapid effects (e.g., claim to work in minutes to hours) or long-lasting effects (e.g., claim to last 24 to 72 hours) likely contain a contaminant, the FDA stated.